In line with increasingly stringent European regulations, European Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) rules and guidelines for medicinal products continue to evolve. Our speakers will discuss the latest developments, including in particular:
- The new 2013 EU GDP guidelines for medicinal products;
- Draft EU GMP guidelines for active substances and excipients;
- Draft EU GDP guidelines for active substances; and
- The ongoing revision of several parts of the EU GMP Guide.
Please join us for this timely webinar, presented by Maurits Lugard and Mike Beckers, and intended to keep you informed of the latest developments.
Tuesday April 22, 2014
11:00 a.m. - 12:00 p.m. Eastern Time
8:00 a.m. - 9:00 a.m. Pacific Time
5:00 p.m. - 6:00 p.m. Central European Time
Maurits J.F. Lugard
This event is open to in-house counsel and regulatory personnel at pharmaceutical companies and regulators.
For more information or questions, please contact us at email@example.com
Sidley Austin LLP is an accredited MCLE provider in IL, NY and CA. CLE credit for this program is pending.